Concepedia
Statistics
Publications
5
Citations
761
H-Index
Active since
2010
Affiliations
GlaxoSmithKline (United States)(Current)
South College
The University of Texas MD Anderson Cancer Center
Christian Sherk is an author at GlaxoSmithKline (United States) specializing in pharmacology, molecular oncology, and medicine.
Publications per year
2010–2022
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess et al. · ACS Medicinal Chemistry Letters · 2010 · 372 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill et al. · Nature Cancer · 2021 · 280 citations · Full text
Medicine, Oncology, Pharmacology +8
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors
Hong Lin, Mark J. Schulz, Ren Xie et al. · ACS Medicinal Chemistry Letters · 2012 · 39 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230
Christina Blackwell, Christian Sherk, Maggie Fricko et al. · Oncotarget · 2016 · 39 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Andrew Fedoriw, Leilei Shi, Shane W. O’Brien et al. · Cancer Immunology Research · 2022 · 31 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 5